老年晚期卵巢癌患者的治疗与结局:一项全国性分析
该研究基于荷兰癌症登记库2002至2013年确诊的10440例晚期上皮性卵巢癌(EOC)患者,按年龄、分期和诊断时期分层,分析老年(≥70岁)患者治疗模式随时间变化及与手术死亡率和生存的关系,发现年轻与老年患者间存在较大治疗差异,老年患者未治疗比例大且生存差距大。
要点
- 随年龄增长,接受(新)辅助治疗的患者减少。
- 老年患者随时间更少接受治疗(OR 0.73;95%CI 0.58-0.92,2002-2004 vs 2011-2013)。
- 若接受治疗,更多接受标准治疗,术后30天死亡率从4.5%降至1.9%(2005-2007 vs 2011-2013)。
核心结论
- 年轻与老年患者之间存在较大治疗差异,老年患者选择适合根治性手术可能随时间改善,但大量且增加的未治疗老年患者及较大生存差距提示老年EOC患者照护有进一步改善机会。
研究设计与样本
- 基于荷兰癌症登记库的全国性分析,纳入2002至2013年确诊的晚期(FIGO IIB及以上)上皮性卵巢癌(EOC)女性10440例,按年龄、分期和诊断时期分层,老年定义为≥70岁。
主要发现
- 随年龄增长,接受(新)辅助治疗的患者减少。
- 老年患者随时间更少接受治疗(OR 0.73;95%CI 0.58-0.92,2002-2004 vs 2011-2013)。
- 若接受治疗,更多接受标准治疗,术后30天死亡率从4.5%降至1.9%(2005-2007 vs 2011-2013)。
- 所有年龄组治疗从初次手术转向初次化疗,70-79岁患者联合治疗在2002-2004至2011-2013年间增加5%。
- 2008-2010年确诊患者5年相对生存率:<70岁为34%,老年患者为18%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To provide an overview of treatment strategies for elderly patients with advanced stage epithelial ovarian cancer (EOC) in daily practice, evaluate changes over time and relate this to surgical mortality and survival. METHODS: All women diagnosed with advanced stage (FIGO IIB and higher) EOC between 2002 and 2013 were selected from the Netherlands Cancer Registry (n=10,440) and stratified by age, stage and period of diagnosis. Elderly patients were defined as aged ≥70years. Time trends in treatment patterns and postoperative mortality were described by age category and tested using multivariable logistic regression. Relative survival was calculated. RESULTS: With advancing age, less patients received ((neo-)adjuvant) treatment. Over time, elderly patients were less often treated (OR 2002-2004 versus 2011-2013: 0.73; 95%CI:0.58-0.92). But if treated, more often standard treatment was provided and 30-day postoperative mortality decreased from 4.5% to 1.9% between 2005 and 2007 and 2011-2013. In all age categories treatment shifted from primary surgery towards primary chemotherapy, in patients aged 70-79years combination therapy increased (+5%) between 2002 and 2004 and 2011-2013. Five-year relative survival for patients diagnosed in 2008-2010 aged <70years was 34% compared to 18% for elderly patients. CONCLUSION: Large treatment differences exist between younger and elderly patients. Over time, selection of elderly patients eligible for curative surgical treatment may have improved. More elderly patients were treated with neoadjuvant chemotherapy while less patients underwent surgery and simultaneously postoperative mortality decreased. However, the large and increasing number of elderly patients without treatment and the large survival gap suggests opportunities for further improvements in the care for elderly EOC patients.
引用
- Schuurman MS, Kruitwagen RFPM, Portielje JEA, et al. Treatment and outcome of elderly patients with advanced stage ovarian cancer: A nationwide analysis. Gynecol Oncol. 2018. PMID: 29514738. doi:10.1016/j.ygyno.2018.02.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。